|
Date of decision
|
18 November 2005
|
|
|
Case number
|
T 0531/04
- 3.3.04
|
|
|
Application number
|
98306332.2
|
|
|
|
|
|
|
Title of the application
|
Combination therapy for eradicating detectable HCV-RNA in
patients having chronic hepatitis C infection
|
|
|
Applicant name
|
SCHERING CORPORATION
|
|
|
Opponent name
|
Alfa Wassermann S.p.A.
Teva Pharmaceutical Industries Ltd.
Sandoz GmbH
Appelt, Christian W.
Meduna Arzneimittelfabrik GmbH
|
|
|
|
|
Keywords
Objection under Art. 123(3) EPC (not admitted); right to priority
(no); inventive step (no); referral to the EBA (no)
|
|
|
|
|
